Tim Edwards
Chairman bei SCHRODERS CAPITAL GLOBAL INNOVATION TRUST PLC - INOV
Vermögen: 48 433 $ am 31.03.2024
Profil
Tim Edwards is currently the Executive Chairman at Karus Therapeutics Ltd., the Independent Non-Executive Chairman at Schroders Capital Global Innovation Trust Plc, the Non-Executive Chairman at STORM Therapeutics Ltd., the Chairman at Institute For Research In Schools, the Chairman at Endlyz Therapeutics, Inc., the Chairman at Endlyz UK Ltd., the Senior Independent Director at Record Plc, the Non-Executive Director at Astronautx Ltd., and a Governor at Magdalen College School.
Previously, he served as the President & Chief Executive Officer at Cellzome, Inc., the Chairman at The Bioindustry Association, the Chairman at Atopix Therapeutics Ltd., a Director at Innovate UK, a Director-Corporate Finance at NatWest Markets, a Non-Executive Director at Cell Therapy Catapult Ltd., and a Director at Ervaxx Ltd.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
RECORD PLC
0,03% | 31.03.2023 | 60 000 ( 0,03% ) | 48 433 $ | 31.03.2024 |
Aktive Positionen von Tim Edwards
| Unternehmen | Position | Beginn |
|---|---|---|
| RECORD PLC | Director/Board Member | 21.03.2018 |
| SCHRODERS CAPITAL GLOBAL INNOVATION TRUST PLC - INOV | Chairman | 04.06.2021 |
STORM Therapeutics Ltd.
 STORM Therapeutics Ltd. BiotechnologyHealth Technology Storm Therapeutics Ltd. develops small molecule drugs that target RNA-modifying enzymes. It offers research and development of drug molecules for the treatment of specific cancers. The company was founded by Anthony Kouzarides and Eric Miska on April 21, 2015 and is headquartered in Cambridge, the United Kingdom. | Chairman | 01.06.2015 |
| Institute For Research In Schools | Chairman | 01.02.2018 |
Magdalen College School
 Magdalen College School Other Consumer ServicesConsumer Services Magdalen College School is an educational institution located in Brackley, UK. The school offers admission to students from year 6 to year 11 and sixth form. The school provides flu and COVID vaccinations to students in years 7-11. The school regularly organizes events such as open evenings, summer showcases, and athletics competitions. The school also offers teacher training programs through the Grand Union Training Partnership. The school communicates with parents through notices and social media. Magdalen College School was founded by Isaac Wodhams. | Corporate Officer/Principal | - |
Karus Therapeutics Ltd.
 Karus Therapeutics Ltd. BiotechnologyHealth Technology Karus Therapeutics Ltd. provides therapies for treatment of cancer and inflammatory diseases. It offers HDAC6 and PI3K inhibitors for the treatment of cancer. The firm’s products in pipeline include KA-2237, KAR4000 Series and KAR3000 Series for the treatment of chronic inflammation, haematological malignancies, and solid tumours. The company was founded in July 2005 by Arasu Ganesan, Graham Keith Packham and Paul Townsend and is headquartered in Abingdon, the United Kingdom. | Chairman | 01.01.2018 |
Astronautx Ltd.
 Astronautx Ltd. Miscellaneous Commercial ServicesCommercial Services Astronautx Ltd. engages in biotechnology company. The company was founded on April 1, 2019 and is headquartered in Reading, the United Kingdom. | Director/Board Member | 01.09.2019 |
Endlyz Therapeutics, Inc.
 Endlyz Therapeutics, Inc. BiotechnologyHealth Technology Endlyz Therapeutics, Inc. is an American company that operates in the biotechnology industry. | Chairman | - |
| Endlyz UK Ltd. | Chairman | - |
Ehemalige bekannte Positionen von Tim Edwards
| Unternehmen | Position | Ende |
|---|---|---|
| ░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░░░░░░░░░ ░░░░ | ░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░ ░░░░░░░ ░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
| ░░░ ░░░░░░░░░░░ ░░░░░░░░░░░ | ░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░ ░░░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| RECORD PLC | Finance |
| Private Unternehmen | 15 |
|---|---|
Innovate UK
 Innovate UK Miscellaneous Commercial ServicesCommercial Services Innovate UK promotes, supports and invests in technology research, development, and commercialization. The firm provides access to information about the funding and support opportunities through a range of channels. The company was founded on July 1, 2007 and is headquartered in Swindon, the United Kingdom. | Commercial Services |
| NatWest Markets | Finance |
Karus Therapeutics Ltd.
Karus Therapeutics Ltd. BiotechnologyHealth Technology Karus Therapeutics Ltd. provides therapies for treatment of cancer and inflammatory diseases. It offers HDAC6 and PI3K inhibitors for the treatment of cancer. The firm’s products in pipeline include KA-2237, KAR4000 Series and KAR3000 Series for the treatment of chronic inflammation, haematological malignancies, and solid tumours. The company was founded in July 2005 by Arasu Ganesan, Graham Keith Packham and Paul Townsend and is headquartered in Abingdon, the United Kingdom. | Health Technology |
The Bioindustry Association
 The Bioindustry Association Miscellaneous Commercial ServicesCommercial Services The BioIndustry Association is a UK-based organization that represents the life sciences and biotech industry. The British company's mission is to facilitate and connect the ecosystem to help businesses start, grow, and deliver world-changing innovation. The non-profit company was founded by Cormac G. Kilty and Simon Geoffrey Best, and Steve Bates has been the CEO of the company since 2012. | Commercial Services |
Cellzome, Inc.
 Cellzome, Inc. Pharmaceuticals: MajorHealth Technology Part of GSK Plc, Cellzome, Inc. develops immune-inflammation therapy. The private company is based in Philadelphia, PA. The company was founded by Spyridon Artavanis-Tsakonas, Stelios Papadopoulos. | Health Technology |
Atopix Therapeutics Ltd.
 Atopix Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Atopix Therapeutics Ltd. develops medicines to treat atopic dermatitis and severe asthma. The firm also assess the safety and pharmacokinetic profile of its back-up molecule ATX2417 in a phase I study. The company was incorporated on October 10, 2012 and is headquartered in Abingdon, the United Kingdom. | Health Technology |
Schroders Capital Global Innovation Trust Plc
 Schroders Capital Global Innovation Trust Plc Investment Trusts/Mutual FundsMiscellaneous Schroders Capital Global Innovation Trust Plc is a closed-end investment trust. Its investment objective is to achieve long-term capital growth through investing in a portfolio consisting predominantly of UK companies, both quoted and unquoted. The company was founded on January 26, 2015 and is headquartered in London, the United Kingdom. | Miscellaneous |
Cell Therapy Catapult Ltd.
 Cell Therapy Catapult Ltd. BiotechnologyHealth Technology Cell Therapy Catapult Ltd. engages in the development, delivery, and commercializing of cell and gene therapy. The company was founded in 2012 and is headquartered in London, the United Kingdom. | Health Technology |
Magdalen College School
Magdalen College School Other Consumer ServicesConsumer Services Magdalen College School is an educational institution located in Brackley, UK. The school offers admission to students from year 6 to year 11 and sixth form. The school provides flu and COVID vaccinations to students in years 7-11. The school regularly organizes events such as open evenings, summer showcases, and athletics competitions. The school also offers teacher training programs through the Grand Union Training Partnership. The school communicates with parents through notices and social media. Magdalen College School was founded by Isaac Wodhams. | Consumer Services |
STORM Therapeutics Ltd.
STORM Therapeutics Ltd. BiotechnologyHealth Technology Storm Therapeutics Ltd. develops small molecule drugs that target RNA-modifying enzymes. It offers research and development of drug molecules for the treatment of specific cancers. The company was founded by Anthony Kouzarides and Eric Miska on April 21, 2015 and is headquartered in Cambridge, the United Kingdom. | Health Technology |
Ervaxx Ltd.
 Ervaxx Ltd. Pharmaceuticals: MajorHealth Technology Ervaxx Ltd. is a British company that pioneers the use of dark antigens to deliver targeted immunotherapies for treating and preventing cancer. The company was founded in 2016 by George Kassiotis, Drew M. Pardoll and is based in London, UK. The company's powerful, proprietary edapt platform has been developed to discover and validate dark antigens providing an in-depth assessment of candidate antigens on primary tumor cells along with their immunogenic potential. Ervaxx is advancing a pipeline of T cell receptor-based therapies, off-the-shelf cancer vaccines, and other immunotherapies leveraging these insights into the role of dark antigens in cancer. | Health Technology |
| Institute For Research In Schools | |
Astronautx Ltd.
Astronautx Ltd. Miscellaneous Commercial ServicesCommercial Services Astronautx Ltd. engages in biotechnology company. The company was founded on April 1, 2019 and is headquartered in Reading, the United Kingdom. | Commercial Services |
Endlyz Therapeutics, Inc.
Endlyz Therapeutics, Inc. BiotechnologyHealth Technology Endlyz Therapeutics, Inc. is an American company that operates in the biotechnology industry. | Health Technology |
| Endlyz UK Ltd. |
